NEW PATENTS

Sr no	Patent number	name	company	INDICATION	REMARKS, WAIT FOR STR TO APPEAR
1	WO-2017201241	LAROTRECTIB	INDIVIDUAL	CANCER
2	WO-2017199264	BELINOSTAT	BIOPHORE	Peripheral T-cell lymphoma
3	WO-2017198202	NINTEDANIB	SHANGHAI	Idiopathic pulmonary fibrosis; Metastatic non small cell lung cancer
4	WO-2017198102	GRAZOPREVIR	SHENZEN	Hepatitis C virus NS3 protease inhibitor
5	WO-2017197904	PALBOCICLIB	SHANGHAI	Metastatic breast cancer
6	EP-03243824	IBRUTINIB	ZENTIVA	B-cell lymphoma; Chronic lymphocytic leukemia; Graft versus host disease; Lymphoplasmacytic lymphoma; Macroglobulinemia; Mantle cell lymphoma; Marginal zone B-cell lymphoma; Non-Hodgkin lymphoma
7	US-20170335357	DROXIDOPA	DIVIS	Hypotension; Movement disorder; Orthostatic hypotension
8	WO-2017197604	CRIZOTINIB	ASYMCHEM	Carcinoma; Metastatic non small cell lung cancer; Non-small-cell lung cancer
9	WO-2017198085	EPIRUBICIN	ZHEJIANG	Bladder tumor; Breast tumor; Carcinoma; Lung tumor; Uterine cervix tumor
10	WO-2017199039	OBETICHOLIC ACID	NZP	Primary biliary cirrhosis
11	WO-2017199033	OBETICHOLIC ACID	NZP	Primary biliary cirrhosis
12	WO-2017199036	OBETICHOLIC ACID	NZP	Primary biliary cirrhosis